Gregg JP - Search Results

1

In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia.

Abbey CK, Borowsky AD, McGoldrick ET, Gregg JP, Maglione JE, Cardiff RD, Cherry SR. Abbey CK, et al. Among authors: gregg jp. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11438-43. doi: 10.1073/pnas.0404396101. Epub 2004 Jul 26. Proc Natl Acad Sci U S A. 2004. PMID: 15277673 Free PMC article.

2

Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography.

Abbey CK, Borowsky AD, Gregg JP, Cardiff RD, Cherry SR. Abbey CK, et al. Among authors: gregg jp. J Mammary Gland Biol Neoplasia. 2006 Apr;11(2):137-49. doi: 10.1007/s10911-006-9020-6. J Mammary Gland Biol Neoplasia. 2006. PMID: 17091397 Review.

3

Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ.

Namba R, Maglione JE, Young LJ, Borowsky AD, Cardiff RD, MacLeod CL, Gregg JP. Namba R, et al. Among authors: gregg jp. Mol Cancer Res. 2004 Aug;2(8):453-63. Mol Cancer Res. 2004. PMID: 15328372

4

Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.

Namba R, Young LJ, Maglione JE, McGoldrick ET, Liu S, Wurz GT, DeGregorio MW, Borowsky AD, MacLeod CL, Cardiff RD, Gregg JP. Namba R, et al. Among authors: gregg jp. Breast Cancer Res. 2005;7(6):R881-9. doi: 10.1186/bcr1317. Epub 2005 Sep 13. Breast Cancer Res. 2005. PMID: 16280035 Free PMC article.

5

Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.

Namba R, Young LJ, Abbey CK, Kim L, Damonte P, Borowsky AD, Qi J, Tepper CG, MacLeod CL, Cardiff RD, Gregg JP. Namba R, et al. Among authors: gregg jp. Clin Cancer Res. 2006 Apr 15;12(8):2613-21. doi: 10.1158/1078-0432.CCR-05-2170. Clin Cancer Res. 2006. PMID: 16638874

6

EMT tumorigenesis in the mouse mammary gland.

Damonte P, Gregg JP, Borowsky AD, Keister BA, Cardiff RD. Damonte P, et al. Among authors: gregg jp. Lab Invest. 2007 Dec;87(12):1218-26. doi: 10.1038/labinvest.3700683. Epub 2007 Oct 8. Lab Invest. 2007. PMID: 17922020 Free PMC article.

7

Histopathology as a predictive biomarker: strengths and limitations.

Cardiff RD, Gregg JP, Miller JW, Axelrod DE, Borowsky AD. Cardiff RD, et al. Among authors: gregg jp. J Nutr. 2006 Oct;136(10):2673S-5S. doi: 10.1093/jn/136.10.2673S. J Nutr. 2006. PMID: 16988145 Free article. No abstract available.

8

Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin.

Jessen KA, Liu SY, Tepper CG, Karrim J, McGoldrick ET, Rosner A, Munn RJ, Young LJ, Borowsky AD, Cardiff RD, Gregg JP. Jessen KA, et al. Among authors: gregg jp. Breast Cancer Res. 2004;6(3):R157-69. doi: 10.1186/bcr768. Epub 2004 Feb 25. Breast Cancer Res. 2004. PMID: 15084239 Free PMC article.

9

Validation: the new challenge for pathology.

Cardiff RD, Rosner A, Hogarth MA, Galvez JJ, Borowsky AD, Gregg JP. Cardiff RD, et al. Among authors: gregg jp. Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:31-9. doi: 10.1080/01926230490424662. Toxicol Pathol. 2004. PMID: 15209401 Review.

10

Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.

Maglione JE, McGoldrick ET, Young LJ, Namba R, Gregg JP, Liu L, Moghanaki D, Ellies LG, Borowsky AD, Cardiff RD, MacLeod CL. Maglione JE, et al. Among authors: gregg jp. Mol Cancer Ther. 2004 Aug;3(8):941-53. Mol Cancer Ther. 2004. PMID: 15299077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters